Ongoing search for effective intrapleural therapy for empyema: Is streptokinase the answer?

American Journal of Respiratory and Critical Care Medicine

Volumn 170, Issue 1, 2004, Pages 1-2

  Lee, Y C Gary ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRINOLYTIC AGENT; STREPTOKINASE;

CLINICAL TRIAL; DISEASE SEVERITY; EDITORIAL; EMPYEMA; HUMAN; MORBIDITY; MORTALITY; NONHUMAN; PRIORITY JOURNAL; THORACOSCOPY; ANIMAL; NOTE; PLEURA EMPYEMA; WOUND DRAINAGE;

ANIMALS; DRAINAGE; EMPYEMA, PLEURAL; FIBRINOLYTIC AGENTS; HUMANS; STREPTOKINASE;

EID: 3242892998     PISSN: 00030805     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (15)

1. Maskell NA, Davies RJO. Effusions from parapneumonic infection and empyema. In: Light RW, Lee YCG, editors. Textbook of pleural diseases. London: Arnold Press; 2003. p. 310-328.
2. Warren P. The surgical treatment of pulmonary and cardiac disease. Available at: http://www.umanitoba.ca/faculties/medicine/history/notes/surgery/ (Date accessed: May 18, 2004).
3. Davies CWH, Gleeson FV, Davies RJO. The British Thoracic Society guidelines on the management of pleural infection. Thorax 2003;58:ii18-ii28.
4. Diacon AH, Theron J, Schuurmans MM, Van de Wal BW, Bolliger CT. Intrapleural streptokinase for empyema and complicated parapneumonic effusions. Am J Respir Crit Care Med 2004;170:49-53.
5. Bouros D, Schiza S, Panagou P, Drositis J, Siafakas N. Role of streptokinase in the treatment of acute loculated parapneumonic pleural effusions and empyema. Thorax 1994;49:852-855.
6. Davies RJO, Traill ZC, Gleeson FV. Randomised controlled trial of intrapleural streptokinase in community acquired pleural infection. Thorax 1997;52:416-421.
7. Bouros D, Schiza S, Patsourakis G, Chalkiadakis G, Panagou P, Siafakas NM. Intrapleural streptokinase versus urokinase in the treatment of complicated parapneumonic effusions. Am J Respir Crit Care Med 1997;155:291-295.
8. Chin NK, Lim TK. Controlled trial of intrapleural streptokinase in the treatment of pleural empyema and complicated parapneumonic effusions. Chest 1997;111:275-279.
9. Strange C, Allen ML, Harley R, Lazarchick J, Sahn SA. Intrapleural streptokinase in experimental empyema. Am Rev Respir Dis 1993;147:962-966.
10. Bouros D, Schiza S, Tzanakis N, Chalkiadakis G, Drositis J, Siafakas NM. Intrapleural urokinase versus normal saline in the treatment of complicated parapneumonic effusions and empyema. Am J Respir Crit Care Med 1999;159:37-42.
11. Simpson G, Roomes D, Heron M. Effects of streptokinase and deoxyribonuclease on viscosity of human surgical and empyema pus. Chest 2000;117:1728-1733.
12. Sasse SA, Jadus MR, Kukes GD. Pleural fluid transforming growth factor-beta1 correlates with pleural fibrosis in experimental empyema. Am J Respir Crit Care Med 2003;168:700-705.
13. Idell S, Mazar A, Cines D, Kuo A, Parry G, Gawlak S, Juarez J, Koenig K, Azghani A, Hadden W, et al. Single-chain urokinase alone or complexed to its receptor in tetracycline-induced pleuritis in rabbits. Am J Respir Crit Care Med 2002;166:920-926.
14. Bean RB. Sir William Osler: aphorisms from his bedside teachings and writings. Available at: http://www.vh.org/adult/provider/history/osler/5.html (Date accessed: May 18, 2004).
15. Wait MA, Sharma S, Hohn J, Dal Nogare A. A randomized trial of empyema therapy. Chest 1997;111:1548-1551.